Q8NFZ5 (TNIP2_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
TNFAIP3-interacting protein 2

Alternative name(s):
A20-binding inhibitor of NF-kappa-B activation 2
Short name=ABIN-2
Fetal liver LKB1-interacting protein

Gene names

Name:	TNIP2
Synonyms:	ABIN2, FLIP1

Organism

Homo sapiens (Human) [Reference proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

cellular organisms › Eukaryota › Opisthokonta › Metazoa › Eumetazoa › Bilateria › Deuterostomia › Chordata › Craniata › Vertebrata › Gnathostomata › Teleostomi › Euteleostomi › Sarcopterygii › Dipnotetrapodomorpha › Tetrapoda › Amniota › Mammalia › Theria › Eutheria › Boreoeutheria › Euarchontoglires › Primates › Haplorrhini › Simiiformes › Catarrhini › Hominoidea › Hominidae › Homininae › Homo

Protein attributes

Sequence length	429 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	Inhibits NF-kappa-B activation by blocking the interaction of RIPK1 with its downstream effector NEMO/IKBKG. Forms a ternary complex with NFKB1 and MAP3K8 but appears to function upstream of MAP3K8 in the TLR4 signaling pathway that regulates MAP3K8 activation. Involved in activation of the MEK/ERK signaling pathway during innate immune response; this function seems to be stimulus- and cell type specific. Required for stability of MAP3K8. Involved in regulation of apoptosis in endothelial cells; promotes TEK agonist-stimulated endothelial survival. May act as transcriptional coactivator when translocated to the nucleus. Enhances CHUK-mediated NF-kappa-B activation involving NF-kappa-B p50-p65 and p50-c-Rel complexes. Ref.2 Ref.8 Ref.10 Ref.11 Ref.12 Ref.14
Subunit structure	Interacts with STK11/LKB1, TNFAIP3, IKBKG, NFKB1, MAP3K8, TEK, RIPK1, CHUK, IKBKB and SMARCD1. Interacts with polyubiquitin. Ref.2 Ref.7 Ref.9 Ref.10 Ref.11 Ref.12 Ref.14 Ref.15
Subcellular location	Cytoplasm. Nucleus Probable Ref.2 Ref.10 Ref.14.
Tissue specificity	Ubiquitously expressed in all tissues examined. Ref.2
Post-translational modification	In vitro phosphorylated by CHUK. Ref.14 Ubiquitinated; undergoes 'Lys-48'-linked polyubiquitination probably leading to constitutive proteasomal degradation which can be impaired by IKK-A/CHUK or IKBKB probbaly involving deubiquitination. Ref.14

Ontologies

Keywords
Biological process	Apoptosis Inflammatory response Transcription Transcription regulation
Cellular component	Cytoplasm Nucleus
Coding sequence diversity	Alternative splicing Polymorphism
Domain	Coiled coil
PTM	Phosphoprotein Ubl conjugation
Technical term	Complete proteome Reference proteome
Gene Ontology (GO)
Biological_process	CD40 signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB I-kappaB kinase/NF-kappaB signaling Inferred from electronic annotation. Source: Ensembl apoptotic process Inferred from electronic annotation. Source: UniProtKB-KW cellular response to lipopolysaccharide Inferred from sequence or structural similarity. Source: UniProtKB inflammatory response Inferred from electronic annotation. Source: UniProtKB-KW interleukin-1-mediated signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB negative regulation of endothelial cell apoptotic process Inferred from direct assay Ref.8. Source: UniProtKB positive regulation of B cell activation Inferred from sequence or structural similarity. Source: UniProtKB positive regulation of I-kappaB kinase/NF-kappaB signaling Inferred from direct assay Ref.14. Source: UniProtKB positive regulation of macrophage activation Inferred from sequence or structural similarity. Source: UniProtKB positive regulation of transcription from RNA polymerase II promoter Inferred from direct assay Ref.10. Source: UniProtKB protein stabilization Inferred from sequence or structural similarity. Source: UniProtKB toll-like receptor 2 signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB toll-like receptor 3 signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB toll-like receptor 9 signaling pathway Inferred from sequence or structural similarity. Source: UniProtKB transcription, DNA-templated Inferred from electronic annotation. Source: UniProtKB-KW
Cellular_component	cytosol Traceable author statement. Source: Reactome nucleus Inferred from electronic annotation. Source: UniProtKB-SubCell
Molecular_function	polyubiquitin binding Inferred from direct assay Ref.13. Source: UniProtKB protein binding Inferred from physical interaction Ref.2Ref.10Ref.11PubMed 14743216Ref.12PubMed 21988832. Source: IntAct protein kinase binding Inferred from direct assay Ref.14. Source: UniProtKB
Complete GO annotation...

Binary interactions

With	Entry	#Exp.	IntAct	Notes
IKBKG	Q9Y6K9	6	EBI-359372,EBI-81279
MAP3K8	P41279	9	EBI-359372,EBI-354900
NFKB1	P19838-1	8	EBI-359372,EBI-1452239
STK11	Q15831	5	EBI-359372,EBI-306838

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 Ref.1 Ref.2 Ref.6 (identifier: Q8NFZ5-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 Ref.3 (identifier: Q8NFZ5-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-107: Missing.

Note: No experimental confirmation available.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 429	429	TNFAIP3-interacting protein 2		PRO_0000322583
Regions
	Region	289 – 347	59	Ubiquitin-binding domain (UBD)
	Coiled coil	29 – 117	89	Potential
	Coiled coil	196 – 226	31	Potential
	Coiled coil	255 – 340	86	Potential
Natural variations
	Alternative sequence	1 – 107	107	Missing in isoform 2. Ref.3		VSP_052701
	Natural variant	249	1	Q → H in patients with gastrointestinal diffuse large cell lymphoma; impairs inhibitory activity on CARD11-induced NF-kappa-B activation. Ref.15 Corresponds to variant rs116129895 [ dbSNP | Ensembl ].		VAR_067969
	Natural variant	255	1	E → K in patients with gastrointestinal diffuse large cell lymphoma; somatic mutation; impairs inhibitory activity on CARD11-induced NF-kappa-B activation and impairs interaction with TNFAIP3. Ref.15 Corresponds to variant rs116412781 [ dbSNP | Ensembl ].		VAR_067970
	Natural variant	396	1	A → V. Ref.3 Ref.6 Corresponds to variant rs2269495 [ dbSNP | Ensembl ].		VAR_039463
Experimental info
	Mutagenesis	62	1	S → A: Reduces phosphorylation. Ref.13 Ref.14
	Mutagenesis	146	1	S → A: Reduces phosphorylation; reduces CHUK-mediated NF-kappa-B activation. Ref.13 Ref.14
	Mutagenesis	309 – 310	2	DF → NA: Abolishes ubiquitin binding. Ref.13
	Mutagenesis	313 – 314	2	ER → AA: Abolishes ubiquitin binding; loss of inhibitory activity on NF-kappa-B activation. Ref.13
	Sequence conflict	153	1	Q → H in CAC34835. Ref.1

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 [UniParc]. Last modified October 1, 2002. Version 1. Checksum: 0F6B049C2B3483DC	FASTA	429	48,700
	10 20 30 40 50 60 MSRDPGSGGW EEAPRAAAAL CTLYHEAGQR LRRLQDQLAA RDALIARLRA RLAALEGDAA 70 80 90 100 110 120 PSLVDALLEQ VARFREQLRR QEGGAAEAQM RQEIERLTER LEEKEREMQQ LLSQPQHERE 130 140 150 160 170 180 KEVVLLRRSM AEGERARAAS DVLCRSLANE THQLRRTLTA TAHMCQHLAK CLDERQHAQR 190 200 210 220 230 240 NVGERSPDQS EHTDGHTSVQ SVIEKLQEEN RLLKQKVTHV EDLNAKWQRY NASRDEYVRG 250 260 270 280 290 300 LHAQLRGLQI PHEPELMRKE ISRLNRQLEE KINDCAEVKQ ELAASRTARD AALERVQMLE 310 320 330 340 350 360 QQILAYKDDF MSERADRERA QSRIQELEEK VASLLHQVSW RQDSREPDAG RIHAGSKTAK 370 380 390 400 410 420 YLAADALELM VPGGWRPGTG SQQPEPPAEG GHPGAAQRGQ GDLQCPHCLQ CFSDEQGEEL LRHVAECCQ
	Isoform 2 [UniParc]. Checksum: 4B145A09A85133BE	FASTA	322	36,682
	10 20 30 40 50 60 MQQLLSQPQH EREKEVVLLR RSMAEGERAR AASDVLCRSL ANETHQLRRT LTATAHMCQH 70 80 90 100 110 120 LAKCLDERQH AQRNVGERSP DQSEHTDGHT SVQSVIEKLQ EENRLLKQKV THVEDLNAKW 130 140 150 160 170 180 QRYNASRDEY VRGLHAQLRG LQIPHEPELM RKEISRLNRQ LEEKINDCAE VKQELAASRT 190 200 210 220 230 240 ARDAALERVQ MLEQQILAYK DDFMSERADR ERAQSRIQEL EEKVASLLHQ VSWRQDSREP 250 260 270 280 290 300 DAGRIHAGSK TAKYLAADAL ELMVPGGWRP GTGSQQPEPP AEGGHPGAAQ RGQGDLQCPH 310 320 CLQCFSDEQG EELLRHVAEC CQ

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"Identification of a novel A20-binding inhibitor of nuclear factor-kappaB activation termed ABIN-2." Van Huffel S.C., Delaei F., Heyninck K., De Valck D., Beyaert R. J. Biol. Chem. 276:30216-30223(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
[2]	"An LKB1-interacting protein negatively regulates TNFalpha-induced NF-kappaB activation." Liu W.-K., Chien C.-Y., Chou C.-K., Su J.-Y. J. Biomed. Sci. 10:242-252(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH STK11/LKB1.
[3]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANT VAL-396. Tissue: Kidney epithelium.
[4]	Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C. Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]	"Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. , Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K. Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-396. Tissue: Uterus.
[7]	"Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions." Klinkenberg M., Van Huffel S., Heyninck K., Beyaert R. FEBS Lett. 498:93-97(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TNFAIP3.
[8]	"ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1." Tadros A., Hughes D.P., Dunmore B.J., Brindle N.P. Blood 102:4407-4409(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION.
[9]	"The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2." Hughes D.P., Marron M.B., Brindle N.P. Circ. Res. 92:630-636(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TEK.
[10]	"The A20-binding protein ABIN-2 exerts unexpected function in mediating transcriptional coactivation." Chien C.Y., Liu W.K., Chou C.K., Su J.Y. FEBS Lett. 543:55-60(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SMARCD1.
[11]	"The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis." Liu W.-K., Yen P.-F., Chien C.-Y., Fann M.-J., Su J.-Y., Chou C.-K. Biochem. J. 378:867-876(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH IKBKG.
[12]	"ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability." Lang V., Symons A., Watton S.J., Janzen J., Soneji Y., Beinke S., Howell S., Ley S.C. Mol. Cell. Biol. 24:5235-5248(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH NFKB1; MAP3K8 AND TNFAIP3.
[13]	"Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins." Wagner S., Carpentier I., Rogov V., Kreike M., Ikeda F., Lohr F., Wu C.J., Ashwell J.D., Dotsch V., Dikic I., Beyaert R. Oncogene 27:3739-3745(2008) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITIN-BINDING, MUTAGENESIS OF 309-ASP-PHE-310 AND 313-GLU-ARG-314.
[14]	"A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity." Leotoing L., Chereau F., Baron S., Hube F., Valencia H.J., Bordereaux D., Demmers J.A., Strouboulis J., Baud V. J. Biol. Chem. 286:32277-32288(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CHUK AND IKBKB, UBIQUITINATION, PHOSPHORYLATION, MUTAGENESIS OF SER-62 AND SER-146.
[15]	"A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma." Dong G., Chanudet E., Zeng N., Appert A., Chen Y.W., Au W.Y., Hamoudi R.A., Watkins A.J., Ye H., Liu H., Gao Z., Chuang S.S., Srivastava G., Du M.Q. Clin. Cancer Res. 17:1440-1451(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS HIS-249 AND LYS-255, INTERACTION WITH TNFAIP3, CHARACTERIZATION OF VARIANT LYS-255.
+	Additional computationally mapped references.

Cross-references

Sequence databases
EMBL GenBank DDBJ	AJ304866 mRNA. Translation: CAC34835.1. AF372839 mRNA. Translation: AAM21315.1. AK026176 mRNA. Translation: BAB15382.1. AK096296 mRNA. Translation: BAG53250.1. CH471131 Genomic DNA. Translation: EAW82514.1. AL121750, AL110117 Genomic DNA. Translation: CAM28233.1. AL110117, AL121750 Genomic DNA. Translation: CAM28252.1. CH471131 Genomic DNA. Translation: EAW82516.1. BC002740 mRNA. Translation: AAH02740.2.
CCDS	CCDS3362.1. [Q8NFZ5-1] CCDS54714.1. [Q8NFZ5-2]
RefSeq	NP_001154999.1. NM_001161527.1. [Q8NFZ5-2] NP_077285.3. NM_024309.3. [Q8NFZ5-1]
UniGene	Hs.368551.
3D structure databases
ProteinModelPortal	Q8NFZ5.
SMR	Q8NFZ5. Positions 400-429.
ModBase	Search...
MobiDB	Search...
Protein-protein interaction databases
BioGrid	122573. 23 interactions.
DIP	DIP-27617N.
IntAct	Q8NFZ5. 18 interactions.
MINT	MINT-97349.
STRING	9606.ENSP00000321203.
PTM databases
PhosphoSite	Q8NFZ5.
Polymorphism databases
DMDM	74715616.
Proteomic databases
MaxQB	Q8NFZ5.
PaxDb	Q8NFZ5.
PRIDE	Q8NFZ5.
Protocols and materials databases
StructuralBiologyKnowledgebase	Search...
Genome annotation databases
Ensembl	ENST00000315423; ENSP00000321203; ENSG00000168884. [Q8NFZ5-1] ENST00000510267; ENSP00000427613; ENSG00000168884. [Q8NFZ5-2]
GeneID	79155.
KEGG	hsa:79155.
UCSC	uc003gff.2. human. [Q8NFZ5-1]
Organism-specific databases
CTD	79155.
GeneCards	GC04M002780.
H-InvDB	HIX0164015.
HGNC	HGNC:19118. TNIP2.
HPA	CAB020818. HPA049886.
MIM	610669. gene.
neXtProt	NX_Q8NFZ5.
PharmGKB	PA134957006.
GenAtlas	Search...
Phylogenomic databases
eggNOG	NOG47580.
HOGENOM	HOG000049046.
HOVERGEN	HBG055553.
InParanoid	Q8NFZ5.
OMA	ADETHQL.
OrthoDB	EOG7M0NRH.
PhylomeDB	Q8NFZ5.
TreeFam	TF332167.
Enzyme and pathway databases
Reactome	REACT_6900. Immune System.
SignaLink	Q8NFZ5.
Gene expression databases
ArrayExpress	Q8NFZ5.
Bgee	Q8NFZ5.
CleanEx	HS_TNIP2.
Genevestigator	Q8NFZ5.
Family and domain databases
InterPro	IPR022008. EABR. [Graphical view]
Pfam	PF12180. EABR. 1 hit. [Graphical view]
ProtoNet	Search...
Other
GeneWiki	TNIP2.
GenomeRNAi	79155.
NextBio	68079.
PRO	Q8NFZ5.
SOURCE	Search...

Entry information

Entry name

TNIP2_HUMAN

Accession

Primary (citable) accession number: Q8NFZ5
Secondary accession number(s): B1AKS4 , B3KTY8, D3DVQ9, Q7L5L2, Q9BQR6, Q9H682

Entry history

Integrated into UniProtKB/Swiss-Prot:	February 26, 2008
Last sequence update:	October 1, 2002
Last modified:	July 9, 2014
This is version 86 of the entry and version 1 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.